| Cancer type |
% methylation |
| B cell-Lymphoma(31) |
20% |
| T cell-Lymphoma(31) |
15% |
| MALT Lymphoma(31) |
67% |
| AP-CML (32) |
40% |
| Childhood B- ALL (33) |
34.4% |
| Adult B- ALL (33) |
26.7% |
| Multiple myeloma (34) |
10% |
| Haematological malignancies (35) |
10.9% |
| Acute Myeloid Leukemia (36) |
0% |
| Acute Myeloid Leukemia (37) |
83% |
| Acute Lymphoblastic leukemia (37) |
85 % |
| Acute Lymphoblastic leukemia (36) |
6% |
| Chronic lymphoblastic leukemia (38) |
14.3% |
| present study (CML) |
42% |
